MedPath

CHIPS (Control of Hypertension in Pregnancy Study): A Pilot Trial

Not Applicable
Completed
Conditions
Transient Hypertension, Pregnancy
Registration Number
NCT00187395
Lead Sponsor
Sunnybrook Health Sciences Centre
Brief Summary

Prior to undertaking CHIPS which will be a large and difficult trial, we believe we need to first determine whether clinicians will comply with the interventions of 'less tight' and 'tight' control of dBP, and whether the interventions will result in differences in mean dBP between groups. A pilot will also allow us to confirm the ability of centres to identify eligible women and the willingness of women to join CHIPS.

Detailed Description

To determine whether 'less tight' control of mild-moderate non-proteinuric maternal hypertension, aiming for a diastolic blood pressure (dBP) of 100mmHg, can decrease the risks of adverse perinatal outcome without increasing maternal risk compared with 'tight' control, aiming for a dBP of 85mmHg.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
132
Inclusion Criteria
  • dBP 90-109mmHg due to pre-existing or gestational hypertension; live fetus(es); and 20-33+6 weeks.
Exclusion Criteria
  • dBP consistently < 85mmHg by home BP monitoring; severe systolic hypertension; proteinuria; contraindication to either arm of the trial or to prolongation of pregnancy; or known lethal/major fetal anomaly.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Mean dBP at 28, 32 and 36 weeks gestation
Secondary Outcome Measures
NameTimeMethod
Clinician compliance with treatment protocols; women's satisfaction with care.

Trial Locations

Locations (1)

Maternal Infant and Reproducting Health Research Unit - CHIPS Data Coordinating Centre

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath